TransCode Therapeutics Analyst Ratings
BenzingaApr 16 22:49
Analysts Offer Insights on Healthcare Companies: Syros Pharmaceuticals (SYRS), Alpine Immune Sciences (ALPN) and TransCode Therapeutics (RNAZ)
TipRanksNov 15, 2023 19:21
HC Wainwright & Co. Reiterates Buy on TransCode Therapeutics, Maintains $3 Price Target
BenzingaOct 25, 2023 00:03
TransCode Therapeutics Analyst Ratings
BenzingaOct 25, 2023 00:00
Promising Preliminary Clinical and Preclinical Results Bolster Buy Rating for TransCode Therapeutics: An Analysis by Emily Bodnar
TipRanksOct 24, 2023 23:56
TransCode Therapeutics Analyst Ratings
BenzingaAug 15, 2023 18:39
H.C. Wainwright Initiates a Buy Rating on TransCode Therapeutics (RNAZ)
TipRanksAug 15, 2023 18:15
Analysts Offer Insights on Healthcare Companies: TransCode Therapeutics (RNAZ), Tarsus Pharmaceuticals (TARS) and Roivant Sciences (ROIV)
TipRanksJun 29, 2023 18:20
TransCode Therapeutics (RNAZ) Gets a Buy From H.C. Wainwright
TipRanksDec 30, 2022 00:10
H.C. Wainwright Sticks to Its Buy Rating for TransCode Therapeutics (RNAZ)
TipRanksDec 1, 2022 22:35
HC Wainwright Adjusts Price Target on TransCode Therapeutics to $6 From $10, Maintains Buy Rating
MT NewswiresNov 15, 2022 23:48
TransCode Therapeutics Analyst Ratings
Benzinga Analyst RatingsNov 15, 2022 19:29
No Data
No Data